{"id":"https://openalex.org/W3200575600","doi":"https://doi.org/10.1093/noajnl/vdab112.002","title":"CLRM-03. BGB-290 AND TEMOZOLOMIDE IN TREATING ISOCITRATE DEHYDROGENASE (IDH)1/2-MUTANT GRADE I-IV GLIOMAS \u2013 A NOVEL MODEL OF AYA TRIAL DEVELOPMENT AND DEPLOYMENT","display_name":"CLRM-03. BGB-290 AND TEMOZOLOMIDE IN TREATING ISOCITRATE DEHYDROGENASE (IDH)1/2-MUTANT GRADE I-IV GLIOMAS \u2013 A NOVEL MODEL OF AYA TRIAL DEVELOPMENT AND DEPLOYMENT","publication_year":2021,"publication_date":"2021-09-21","ids":{"openalex":"https://openalex.org/W3200575600","doi":"https://doi.org/10.1093/noajnl/vdab112.002","mag":"3200575600"},"language":"en","primary_location":{"id":"doi:10.1093/noajnl/vdab112.002","doi":"https://doi.org/10.1093/noajnl/vdab112.002","is_oa":true,"landing_page_url":"https://doi.org/10.1093/noajnl/vdab112.002","pdf_url":"https://academic.oup.com/noa/article-pdf/3/Supplement_4/iv1/40414409/vdab112.002.pdf","source":{"id":"https://openalex.org/S4210237914","display_name":"Neuro-Oncology Advances","issn_l":"2632-2498","issn":["2632-2498"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology Advances","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/noa/article-pdf/3/Supplement_4/iv1/40414409/vdab112.002.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005427159","display_name":"Asher M. Marks","orcid":"https://orcid.org/0000-0002-9913-9912","observed_orcids":["https://orcid.org/0000-0002-9913-9912"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Asher Marks","raw_affiliation_strings":["Yale University, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale University, New Haven, CT, USA","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040738951","display_name":"Ranjit S. Bindra","orcid":"https://orcid.org/0000-0002-3255-0467","observed_orcids":["https://orcid.org/0000-0002-3255-0467"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ranjit Bindra","raw_affiliation_strings":["Yale University, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale University, New Haven, CT, USA","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I32971472"],"apc_list":{"value":2142,"currency":"USD","value_usd":2142},"apc_paid":{"value":2142,"currency":"USD","value_usd":2142},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"3","issue":"Supplement_4","first_page":"iv1","last_page":"iv1"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.005499999970197678,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/idh-mutation","display_name":"IDH mutation","score":0.8009999990463257},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.8849999904632568},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.8709999918937683},{"id":"https://openalex.org/keywords/brcaness","display_name":"BRCAness","score":0.9049999713897705},{"id":"https://openalex.org/keywords/clinical-trial-design","display_name":"clinical trial design","score":0.6919999718666077},{"id":"https://openalex.org/keywords/trial-enrollment-barriers","display_name":"trial enrollment barriers","score":0.546999990940094},{"id":"https://openalex.org/keywords/early-drug-development","display_name":"early drug development","score":0.43700000643730164},{"id":"https://openalex.org/keywords/psychosocial-outcomes","display_name":"psychosocial outcomes","score":0.625}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6926687359809875},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.6576440930366516},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.633833110332489},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6051563620567322},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.6001009345054626},{"id":"https://openalex.org/C150966472","wikidata":"https://www.wikidata.org/wiki/Q3410145","display_name":"Psychosocial","level":2,"score":0.5665007829666138},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.5585052371025085},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5406157374382019},{"id":"https://openalex.org/C2777150147","wikidata":"https://www.wikidata.org/wiki/Q261968","display_name":"Isocitrate dehydrogenase","level":3,"score":0.5074405074119568},{"id":"https://openalex.org/C127848430","wikidata":"https://www.wikidata.org/wiki/Q18027543","display_name":"IDH1","level":4,"score":0.45212841033935547},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.41914287209510803},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3289756178855896},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.21317797899246216},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.13954001665115356},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.1261672079563141},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10967782139778137},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09205245971679688},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.09111946821212769},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/noajnl/vdab112.002","doi":"https://doi.org/10.1093/noajnl/vdab112.002","is_oa":true,"landing_page_url":"https://doi.org/10.1093/noajnl/vdab112.002","pdf_url":"https://academic.oup.com/noa/article-pdf/3/Supplement_4/iv1/40414409/vdab112.002.pdf","source":{"id":"https://openalex.org/S4210237914","display_name":"Neuro-Oncology Advances","issn_l":"2632-2498","issn":["2632-2498"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology Advances","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:7346908","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC8453774","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:8453774","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8453774","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurooncol Adv","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/noajnl/vdab112.002","doi":"https://doi.org/10.1093/noajnl/vdab112.002","is_oa":true,"landing_page_url":"https://doi.org/10.1093/noajnl/vdab112.002","pdf_url":"https://academic.oup.com/noa/article-pdf/3/Supplement_4/iv1/40414409/vdab112.002.pdf","source":{"id":"https://openalex.org/S4210237914","display_name":"Neuro-Oncology Advances","issn_l":"2632-2498","issn":["2632-2498"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology Advances","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320308993","display_name":"CureSearch for Children's Cancer","ror":"https://ror.org/01521js97"},{"id":"https://openalex.org/F4320314868","display_name":"Gateway Foundation","ror":"https://ror.org/00a7g0f84"},{"id":"https://openalex.org/F4320316943","display_name":"Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology","ror":"https://ror.org/01xd6q208"},{"id":"https://openalex.org/F4320317235","display_name":"BeiGene","ror":"https://ror.org/012v2c923"},{"id":"https://openalex.org/F4320318877","display_name":"Northwell Health","ror":"https://ror.org/02bxt4m23"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3200575600.pdf","grobid_xml":"https://content.openalex.org/works/W3200575600.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7135044808","https://openalex.org/W3158479276","https://openalex.org/W4406112755","https://openalex.org/W7165750135","https://openalex.org/W4281616925","https://openalex.org/W3112734515","https://openalex.org/W4388588622","https://openalex.org/W4309014302","https://openalex.org/W3031040380","https://openalex.org/W2617655947"],"abstract_inverted_index":{"Abstract":[0],"DESCRIPTION":[1],"The":[2],"lack":[3],"of":[4,6,24,36,53,57,123,174,280],"enrollment":[5],"AYA":[7,29,153,189,218,239],"patients":[8,157,169,190],"on":[9,237],"clinical":[10,39],"trials":[11,40,186],"is":[12,108,261],"well":[13],"documented":[14],"and":[15,32,45,83,116,234,273,284],"multivariant.":[16],"Here":[17],"we":[18,242],"present":[19],"the":[20,28,33,55,66,96,106,114,140,177,205,213,217,238,254,278,281],"basic":[21],"science,":[22],"examination":[23],"its":[25],"relevance":[26],"to":[27,78,111,147,160,193,226,247,253],"population":[30,219],"specifically,":[31],"parallel":[34],"deployment":[35],"two":[37],"international":[38,135],"via":[41],"a":[42,63,74,124,163,197,262],"pediatric":[43,97],"neuro-oncology":[44],"adult":[46,118],"brain":[47],"tumor":[48],"consortium.":[49],"DISCUSSION":[50],"In":[51],"February":[52],"2017,":[54],"laboratory":[56],"Ranjit":[58],"Bindra,":[59],"MD,":[60],"PhD,":[61],"published":[62],"manuscript":[64],"describing":[65],"finding":[67],"that":[68,105,187,259,264],"tumors":[69],"with":[70,86,162,216,277],"IDH1/2":[71,91],"mutations":[72,92],"induce":[73],"BRCAness":[75],"state":[76],"leading":[77],"PARP":[79],"inhibitor":[80],"(PARPi)":[81],"sensitivity":[82],"synergistic":[84],"interactions":[85],"temozolomide":[87],"chemotherapy":[88],"[2].":[89],"Despite":[90],"being":[93,166],"rare":[94],"in":[95,113,151,200,220,269],"high-grade":[98],"glioma":[99],"population,":[100],"three":[101],"independent":[102],"groups":[103],"confirmed":[104],"incidence":[107],"significantly":[109],"increased":[110],"~30%":[112],"adolescent":[115],"young":[117],"(AYA)":[119],"population.":[120,240],"Upon":[121],"discovery":[122],"high":[125,128],"blood-brain-barrier":[126],"penetrant,":[127],"potency":[129],"PARPi":[130],"by":[131],"BeiGene":[132,289],"Pharmaceuticals,":[133,290],"an":[134,152],"trial":[136,155,165,207],"was":[137,210],"launched":[138],"through":[139,176],"Pacific":[141],"Pediatric":[142],"Neuro-Oncology":[143],"Consortium":[144,181],"(PNOC)":[145],"[3]":[146],"test":[148],"this":[149,260],"drug":[150],"specific":[154],"recruiting":[156],"ages":[158],"13":[159],"25,":[161],"concurrent":[164],"run":[167],"for":[168],"older":[170],"than":[171],"25":[172],"years":[173],"age":[175],"Adult":[178],"Brain":[179],"Tumor":[180],"(ABTC)":[182],"[4].":[183],"While":[184],"most":[185],"enroll":[188],"are":[191],"forced":[192],"assess":[194],"them":[195],"as":[196],"unique":[198,249],"cohort":[199],"post-analysis,":[201],"if":[202],"at":[203],"all,":[204],"PNOC":[206],"mentioned":[208],"above":[209],"designed":[211],"from":[212],"ground":[214],"up":[215],"mind.":[221],"It":[222],"has":[223],"allowed":[224],"us":[225],"base":[227],"initial":[228],"dosing,":[229],"recruitment":[230],"strategies,":[231],"psychosocial":[232],"assessments,":[233],"outcomes,":[235],"specifically":[236],"Ultimately,":[241],"expect":[243],"their":[244],"distinctive":[245],"biology":[246],"yield":[248],"results":[250],"when":[251],"compared":[252],"ABTC":[255],"trial.":[256],"We":[257],"propose":[258],"model":[263],"could":[265],"potentially":[266],"be":[267],"replicated":[268],"other":[270],"disease":[271],"processes":[272],"early":[274,285],"phase":[275,286],"drugs":[276],"buy-in":[279],"pharmaceutical":[282],"industry":[283],"consortiums.":[287],"Acknowledgements:":[288],"PNOC,":[291],"ABTC,":[292],"CureSearch,":[293],"Gateway":[294],"Foundation":[295]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-09-27T00:00:00"}